Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?
Humpert
P M
PM
Department of Medicine I and Clinical Chemistry, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Per.Humpert@med.uni-heidelberg.de
D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000378:metabolism* / Q000473:pathology; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007249:Inflammation; D007328:Insulin / Q000378:metabolism*; D008954:Models, Biological; D018384:Oxidative Stress; D012107:Research Design
D007004:Hypoglycemic Agents; D007328:Insulin; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost; D005947:Glucose